businesspress24.com - Marina Biotech, Inc. to Present at The 10th Annual BIO Investor Forum
 

Marina Biotech, Inc. to Present at The 10th Annual BIO Investor Forum

ID: 1047908

(firmenpresse) - BOTHELL, WA -- (Marketwire) -- 10/19/11 -- Marina Biotech, Inc. (NASDAQ: MRNA), a leading oligonucleotide-based drug discovery and development company, announced today that it will present at The 10th Annual BIO Investor Forum on Wednesday, October 26, 2011, at 6:00 p.m. Eastern Time (3:00 p.m. Pacific Time) at the Palace Hotel in San Francisco. J. Michael French, Marina Biotech President and Chief Executive Officer, will present a corporate overview and business update.

A live audio webcast will be available on the Event Calendar pages of the Investors section of the Company's website at . Please allow time prior to the presentation to register and download any necessary software. A replay of the presentation will be available on the Investors section of the Marina Biotech website under Event Calendar approximately one hour after the live presentation.

About Marina Biotech, Inc.

Marina Biotech is a biotechnology company, focused on the development and commercialization of oligonucleotide-based therapeutics utilizing multiple mechanisms of action including RNA interference (RNAi) and messenger RNA translational blocking. The Marina Biotech pipeline currently includes a clinical program in Familial Adenomatous Polyposis (a precancerous syndrome) and two preclinical programs -- in bladder cancer and malignant ascites. Marina Biotech entered into an exclusive agreement with Debiopharm Group for the development and commercialization of the bladder cancer program. Marina Biotech's goal is to improve human health through the development of RNAi- and oligonucleotide-based compounds and drug delivery technologies that together provide superior therapeutic options for patients. Additional information about Marina Biotech is available at .



Contact:
Marina Biotech, Inc.
Phil Ranker
Interim Chief Financial Officer
(425) 908-3615




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Proteonomix, Inc. (PROT) to Move Forward With Offshore Stem Cell Testing
Tech Council of Maryland Launches Online Career Center
Bereitgestellt von Benutzer: MARKET WIRE
Datum: 19.10.2011 - 15:30 Uhr
Sprache: Deutsch
News-ID 1047908
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

BOTHELL, WA


Phone:

Kategorie:

Biotech


Anmerkungen:


Diese Pressemitteilung wurde bisher 75 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Marina Biotech, Inc. to Present at The 10th Annual BIO Investor Forum
"
steht unter der journalistisch-redaktionellen Verantwortung von

Marina Biotech, Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Marina Biotech, Inc.



 

Who is online

All members: 10 568
Register today: 1
Register yesterday: 2
Members online: 0
Guests online: 60


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.